Clinical Trial Update: Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to determine the maximum tolerated dose, safety, and tolerability of a Rhenium-186 radiopharmaceutical in pediatric patients with recurre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma
• High-grade Glioma

Drugs mentioned

• Rhenium-186 (Rhenium-186 radiopharmaceutical)

Snippet

Sponsor: Plus Therapeutics | Conditions: Ependymoma, High Grade Gliomas | Phase 1 | Status: NOT_YET_RECRUITING